URINARY INCONTINENCE 

Definition 

Urinary incontinence means leaking urine when you don’t want to.

It happens when bladder control is weakened.

Main types:

Stress incontinence: leak with coughing, laughing, or exercise.

Urgency incontinence: sudden urge, leak before reaching toilet.

Mixed type: both stress and urgency symptoms.

(NICE, RCOG)

Prevalence (How common)

RegionEstimated PrevalenceNotes
UK20–40% of adult womenNICE / RCOG
USA30–60%CDC, NIH
Europe20–40%ESHRE, EU studies
Asia5–30% (varies by region)WHO, regional studies
Africa20–30% (wide range)WHO reviews

Commonest in: women after childbirth, post-menopause, or elderly.

Causes / Risk Factors

• Pregnancy and vaginal delivery

• Menopause (low oestrogen)

• Obesity, chronic cough, constipation

• Pelvic surgery or prolapse

• Nerve or bladder problems

• Excess caffeine/alcohol use

Symptoms

• Urine leakage on coughing, sneezing or lifting

• Sudden, strong urge to urinate

• Frequent trips to the toilet (day or night)

• Dampness, odour, embarrassment, avoiding social activities

Investigations

1. History & bladder diary (fluid intake, frequency, leak episodes).

2. Physical exam — pelvic floor and prolapse check.

3. Urine dipstick / culture — rule out infection.

4. Post-void residual scan — check emptying.

5. Bladder diary (3 days) — helps classify type.

6. Further tests (if needed):

• Urodynamics (specialist bladder function test)

• Cystoscopy / imaging (if surgery planned or red flags)

Treatment Options

Stepwise approach (start simple):

1. Lifestyle & Self-help (First-line)

• Weight loss, stop smoking, treat constipation.

• Cut caffeine/alcohol, avoid bladder irritants.

Pelvic Floor Muscle Training (PFMT) for ≥3 months — supervised by physiotherapist.

Bladder training — gradually delay urination.

2. Medications

Antimuscarinics / Beta-3 agonists (e.g. mirabegron): reduce urgency.

Topical vaginal oestrogen: for post-menopausal women.

Duloxetine: for stress incontinence (short-term, selective use).

3. Devices & Minimally Invasive

• Vaginal pessaries (support prolapse).

• Bulking injections around urethra (mild SUI).

• Electrical stimulation / biofeedback therapy.

4. Surgery (when conservative treatment fails)

Mid-urethral sling (tape) — effective but MUST discuss mesh risks.

Colposuspension / autologous sling — alternatives.

Prolapse repair if related.

Long-Term Consequences

Quality-of-life impact: embarrassment, anxiety, low confidence.

Physical: skin irritation, infections, falls in elderly.

Social: withdrawal, reduced work productivity.

Economic: pad costs, laundry, medical expenses.

Key Takeaways

Very common (1 in 3 women) but treatable.

First-line: pelvic-floor exercises & lifestyle changes.

Most women improve without surgery.

Seek help early: effective treatments available at GP or continence clinic.

Remember, ALWAYS consult with your GP and/or your gynecologist for your specific treatment options. Every woman is different!

References:

NICE NG123 (Urinary Incontinence & Pelvic Organ Prolapse, 2019) • RCOG Patient Guidelines • WHO 2023 Global Incontinence Data • CDC (USA) • EAU / ESHRE European Data Reviews

Leave a Reply